Atlas Trials

Intermittent Dosing Of Selumetinib In Childhood NF1 Associated Tumours

Clinical trial NCT03326388 · COMPLETED

Trial details

NCT number
NCT03326388
Sponsor
Great Ormond Street Hospital for Children NHS Foundation Trust
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Neurofibromatosis Type 1Plexiform NeurofibromaOptic Nerve Glioma
Start date
2019-09-26
Primary completion
2024-02-14
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.